Smartleaf Asset Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $164K | Buy |
4,887
+1,154
| +31% | +$38.8K | 0.01% | 648 |
|
|
2025
Q1 | $125K | Buy |
3,733
+582
| +18% | +$19.4K | 0.01% | 744 |
|
|
2024
Q4 | $122K | Buy |
3,151
+316
| +11% | +$12.2K | 0.01% | 750 |
|
|
2024
Q3 | $126K | Buy |
2,835
+59
| +2% | +$2.63K | 0.02% | 637 |
|
|
2024
Q2 | $117K | Sell |
2,776
-34
| -1% | -$1.43K | 0.02% | 530 |
|
|
2024
Q1 | $128K | Buy |
2,810
+109
| +4% | +$4.98K | 0.02% | 463 |
|
|
2023
Q4 | $127K | Buy |
+2,701
| New | +$127K | 0.03% | 387 |
|